Table 3 Allelic diversity and frequency of Pfmsp1 by clinical status and site
Clinical status n (%) | Site n (%) | ||||
|---|---|---|---|---|---|
Allele | Asymptomatic | Symptomatic | Rural | Urban | |
K1 | 44 (28.8) | 43 (30.7) | 46 (26.0) | 41 (35.3) | |
MAD20 | 10 (6.5) | 11 (7.9) | 12 (6.8) | 9 (7.8) | |
RO33 | 17 (11.1) | 12 (8.6) | 16 (9.0) | 13 (11.2) | |
K1 + MAD20 | 28 (18.3) | 28 (20.0) | 40 (22.6) | 16 (13.8) | |
K1 + RO33 | 13 (8.5) | 12 (8.6) | 12 (6.8) | 13 (11.2) |  |
MAD20 + RO33 | 7 (4.6) | 7 (5.0) | 11 (6.2) | 3 (2.6) | |
K1 + MAD20 + RO33 | 34 (22.2) | 27 (19.3) | 40 (22.6) | 21 (18.1) | |